AzTrials
AzTrials

Reward-guided BehaviourNCT04761471

Oscillations in Reward-guided Behavior

A study testing TI transcranial electrical stimulation in people with Reward-guided Behaviour, run by Swiss Federal Institute of Technology at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

While people are reading, talking or playing computer games, their brain cells elicit electrical signals so they could perform these actions. The firing of these cells is not random but is organized in a temporal pattern, such that a group of cells are simultaneously active at a particular frequency. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Reward-guided Behaviour
What is being tested?
TI transcranial electrical stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteSwitzerland
Study dates
1 Feb 2021to 4 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

None listed.

Who cannot join

  • pregnancy
  • epilepsy
  • head traumas
  • implants (cochlear, neurostimulators, cardiac pacemakers, medication infusion device)
  • metal in the brain or skull
  • work in the metal industry
Show all 21Show fewer
  • scars or inflammations on the regions, where the stimulation electrodes are placed
  • administration of antipsychotic or anti-epileptic medication
  • hearing problems or ringing in the ears
  • syncope or fainting spells in the last 5 years
  • severe side-effects after transcranial magnetic stimulation (TMS) or electrical stimulation if participant underwent it before
  • the inability to comply with magnetic resonance imaging (MRI) inclusion criteria if participant underwent it before
  • pregnancy
  • claustrophobia
  • history of brain surgery
  • family member that suffers from epilepsy
  • suffering from medication abuse for more than a year or drug intake
  • taking medications for medical reasons for more than a month
  • receiving of depot injections
  • one or more of the following materials in the body: metallic objects (e.g., dental implants, a metallic splinter in the eye, but not braces); wire, pacemaker or implanted defibrillator; artificial heart valves; vascular grafts; bio-stimulator or nerve stimulator; aneurysm or intracranial clip; cochlear implant; other prostheses or orthoses; implanted medication pump (insulin or pain pump); medicated patch (e.g., nitro-patch, pain patch, nicotine patch, hormone patch, motion sickness patch); other implants; tattoo or jewelry
  • history of any of these illnesses: brain thrombosis, stroke, traumatic brain injury, meningitis, heart attack, prolonged loss of consciousness, migraine, epilepsy

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • ETH Zurich

    Zurich, Schweiz, 8057

Other trials in Switzerland

About this study

Official title: Investigating the Role of Brain Oscillations in Reward-guided Behavior

While people are reading, talking or playing computer games, their brain cells elicit electrical signals so they could perform these actions. The firing of these cells is not random but is organized in a temporal pattern, such that a group of cells are simultaneously active at a particular frequency. The researchers can read the frequency of brain signals and identify their location using different brain-imaging tools like EEG and fMRI. These methods are applied to healthy individuals and do not pose any danger.

The investigators of this project would like to use these techniques to study the brain signals, while healthy participants are making the decisions choosing between 2 rewards, e.g., 2 food items. Participants who have depression show different behavior while performing decision-making tasks and the investigation of processes that underlie them will lead to a better understanding of this disease.

Furthermore, there is another category of tools, which help to study the brain. This category includes electrical stimulation, which mimics the electrical pattern that brain cells elicit. Application of external electrical stimulation can enhance this pattern or disrupt it and this process will affect the behavior of a person. Recent investigations have led to the development of a new stimulation technique that allows targeting deep brain regions. The investigators of this project want to apply this method to change the performance of healthy participants in the tasks on decision-making. If this experiment is successful, then stimulation can be used as a therapy for participants with depression.

Being tested
TI transcranial electrical stimulation
Keywords
Brain oscillations, Neural oscillations, Transcranial electrical stimulation tCS, Temporal Interference stimulation TI, Decision-making

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TI transcranial electrical stimulationDevice

    Participants will undergo transcranial electrical stimulation, which will be delivered with low current amplitudes (<= 2 mA) established with international safety guidelines for electrical stimulation. Threshold for the current amplitude will be established by participants themselves, such that they cannot distinguish when stimulation is applied and not applied.

    Duration of stimulation will not last longer than 30 minutes.

Study groups in NCT04761471
Study groupRoleWhat they receive
TI stimulationExperimentalTemporal interference (TI) stimulation is a type of low-intensity transcranial electrical stimulation with alternating current (tACS). In case of TI stimulation, 2 electric fields in kHz range are delivered to 4 electrodes, which are placed on the surface of the skull, to modulate neural oscillations.
Receives: Device: TI transcranial electrical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy

    Accuracy will be collected with a keyboard and a mouse

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  2. Reaction time

    Reaction time will be collected with a keyboard and a mouse

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  3. Fixations

    Fixations of the gaze on the screen will be recorded with an eye-tracker.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  4. Saccades

    Saccades (a type of the eye movement) will be recorded with an eye-tracker.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  5. Blood oxygenation level dependent (BOLD)

    BOLD signal is measured with functional magnetic resonance imaging (fMRI) experiment.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  6. Brain oscillations in delta band

    Oscillations within the range from 0.5 Hz to 4 Hz will be measured with electroencephalography (EEG).

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  7. Brain oscillations in theta band

    Oscillations within the range from 4 Hz to 8 Hz will be measured with EEG.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  8. Brain oscillations in alpha band

    Oscillations within the range from 8 Hz to 12 Hz will be measured with EEG.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  9. Brain oscillations in beta band

    Oscillations within the range from 12 Hz to 30 Hz will be measured with EEG.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  10. Brain oscillations in low gamma band

    Oscillations within the range from 30 Hz to 70 Hz will be measured with EEG.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

  11. Brain oscillations in high gamma band

    Oscillations within the range from 70 Hz to 250 Hz will be measured with EEG.

    Measured: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2021
  2. Study start1 Feb 2021
  3. Primary completion22 Nov 2022
  4. Study completion4 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
The same participants receive placebo/sham stimulation and active stimulation on different sessions separated with 1 week or within the same session. The sequence of sham/placebo and active stimulation will be randomized.
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04761471
Sponsor's protocol ID
TI_Reward
Status last verified
Dec 2023
First submitted
5 Feb 2021
Last updated
13 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing TI transcranial electrical stimulation in people with Reward-guided Behaviour, run by Swiss Federal Institute of Technology at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy (time frame: Continuously while participants perform a cognitive task (circa 2 hours) with and without TI stimulation.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in